GMO

GMO, formally Grantham, Mayo, Van Otterloo & Co. LLC, is an American investment management firm headquartered in Boston. The company was established in 1977 by Jeremy Grantham, Dick Mayo, and Eijk van Otterloo, three investment professionals whose backgrounds included portfolio management and, in Grantham and Mayo's case, the earlier creation of Batterymarch Financial Management. GMO began as a conservative, value-oriented money manager and developed an investment philosophy centered on valuation, long-term market cycles, and the tendency of asset prices to move back toward historical norms. The firm is particularly associated with contrarian investing. Its research process uses quantitative analysis, historical data, and estimates of expected returns to identify situations in which markets or asset classes appear substantially overvalued or undervalued. This approach has often produced a cautious or bearish view during periods when market prices were rising rapidly. GMO has been credited with identifying major bubbles, including Japan's late-1980s asset-price boom, the dot-com bubble, and the United States housing and credit bubble of the 2000s. Its investment process is designed to position portfolios for long-term outcomes rather than to follow short-term market momentum. GMO has managed equity, fixed-income, emerging-market, and asset-allocation strategies. Although the firm's public identity is strongly linked to value investing and defensive portfolio construction, it has also operated strategies with different risk and return characteristics. These have included emerging-country debt investments and periods in which the firm held a constructive view of emerging-market equities. In 1994, GMO acquired a fund founded by Bill Nemerever and Thomas Cooper that invested in defaulted bank loans and Brady Bonds; the strategy subsequently became associated with the GMO Emerging Country Debt Fund. The firm's contrarian positioning has produced a cyclical business pattern. GMO's investment views can be rewarded after bubbles deflate or valuations normalize, but the same positioning can underperform during prolonged bull markets, particularly when growth stocks and other expensive assets continue to rise. Some United States pension clients reportedly placed mandates on watchlists or ended them during periods of shorter-term underperformance, favoring managers with more optimistic market assumptions. GMO's assets under management reached a reported peak of approximately $155 billion in 2007, but later declined and did not return to that high-water mark according to the referenced account. GMO has maintained an international presence beyond Boston, with offices listed in Amsterdam, London, San Francisco, Singapore, Sydney, and Tokyo. The firm has also expanded through selected strategic activity, including the acquisition of Japan-based equity manager Usonian Investments in July 2020. In October 2020, it launched its Equity Dislocation strategy, which returned 13.7% during the 2022 stock-market decline according to the referenced material. In January 2023, GMO expressed the view that a future market resurgence could be led by deep-value stocks, meaning companies trading at especially low valuation multiples. The company remains best understood as a research-led institutional asset manager whose distinctive brand rests on disciplined valuation analysis, long investment horizons, and willingness to take positions that differ from prevailing market consensus. Its history also illustrates the commercial trade-off of contrarian management: the approach can gain credibility after major market reversals while facing client pressure during extended periods in which expensive assets continue to outperform.

GMO was founded in Boston in 1977 by Jeremy Grantham, Dick Mayo, and Eijk van Otterloo. Grantham and Mayo had previously founded Batterymarch Financial Management in 1969, while van Otterloo had worked with Grantham. The new firm was created as a conservative, value-oriented money manager and took its name from the surnames of its founders. From its early years, GMO developed a style based on valuation, quantitative research, and long-term market behavior. Grantham's analytical approach emphasized the historical relationship between asset prices and fundamentals. When prices moved far above or below long-term norms, GMO sought to position portfolios for eventual normalization. This framework gave the firm a contrarian character and often led it to adopt defensive or bearish views during periods of strong market optimism. GMO's research became associated with several major market calls. The firm identified risks in Japan's asset-price bubble, the dot-com boom, and the United States housing and credit bubble of the 2000s. These calls supported GMO's reputation for recognizing situations in which market prices had become detached from underlying economic values. At the same time, the strategy exposed the firm to long periods of relative underperformance when expensive growth assets continued to appreciate. Its long investment horizon and strict adherence to valuation principles could be difficult for clients evaluating managers over shorter measurement periods. The founders' roles changed over time. Van Otterloo stopped participating in day-to-day money management in 1996 and was regarded as retired. Mayo left the firm in December 2001 to run Game Creek Capital with his son. Grantham remained the public face of GMO's investment philosophy and continued to shape its research and strategic outlook, although the referenced material does not provide a complete chronology of his formal executive titles. GMO expanded beyond its original conservative equity and asset-allocation identity. In 1994, it acquired a fund established by Bill Nemerever and Thomas Cooper that specialized in defaulted bank loans and Brady Bonds. The acquired capability became the GMO Emerging Country Debt Fund and added emerging-market sovereign and distressed-debt exposure to the firm's platform. GMO also maintained periods of positive investment views on emerging-market equities, demonstrating that its contrarian philosophy did not always imply a uniformly defensive stance. The firm's assets under management grew substantially and reportedly reached approximately $155 billion in 2007. Assets later declined as the investment environment changed and as some institutional clients reduced or terminated mandates during periods when GMO's cautious positioning lagged bullish markets. The firm therefore experienced a cyclical relationship between investment outcomes and asset growth: market corrections could validate its views and attract mandates, while prolonged rallies could create client pressure. In 2016, GMO reduced its workforce by approximately 10% from a staff of about 650. The reduction reportedly included the chief executive, but the supplied reference does not name that individual. GMO subsequently continued to develop its international platform, with offices in Amsterdam, London, San Francisco, Singapore, Sydney, and Tokyo in addition to Boston. In July 2020, GMO acquired Usonian Investments, a Japan-based equity manager. In October of the same year, it launched the Equity Dislocation strategy. The strategy reportedly returned 13.7% during the 2022 stock-market decline, a result consistent with GMO's interest in valuation dislocations and market reversals. In January 2023, the firm argued that deep-value stocks could lead a future phase of market resurgence. GMO's enduring identity is consequently that of an institutional asset manager built around mean reversion, valuation discipline, and willingness to diverge from market consensus.

• 2023

  GMO emphasizes deep-value opportunities

  [1]GMO LLCen.wikipedia.org

  The firm stated that deeply discounted value stocks could lead a future phase of market recovery.

• 2020

  Usonian Investments acquisition

  [1]GMO LLCen.wikipedia.org

  GMO acquired Japan-based equity manager Usonian Investments.

• 2020

  Equity Dislocation strategy launches

  [1]GMO LLCen.wikipedia.org

  GMO launched the Equity Dislocation strategy in October, targeting opportunities created by significant market dislocations.

• 2016

  Workforce reduction

  [1]GMO LLCen.wikipedia.org

  The firm reduced its staff by about 10% from a workforce of approximately 650 people.

• 2007

  Reported assets under management peak

  [1]GMO LLCen.wikipedia.org

  GMO reportedly reached approximately $155 billion in assets under management, its cited historical peak.

• 2001

  Mayo departs GMO

  [1]GMO LLCen.wikipedia.org

  Dick Mayo left GMO in December 2001 to run Game Creek Capital with his son.

• 1996

  Van Otterloo leaves day-to-day money management

  [1]GMO LLCen.wikipedia.org

  Eijk van Otterloo ceased his day-to-day money-management role and was subsequently regarded as retired.

• 1994

  GMO acquires an emerging-country debt fund

  [1]GMO LLCen.wikipedia.org

  GMO acquired a fund focused on defaulted bank loans and Brady Bonds, which became associated with the GMO Emerging Country Debt Fund.

• 1977

  GMO is established in Boston

  [1]GMO LLCen.wikipedia.org

  Jeremy Grantham, Dick Mayo, and Eijk van Otterloo founded the firm as a conservative, value-oriented investment manager.

• 1969

  Batterymarch Financial Management is founded

  [1]GMO LLCen.wikipedia.org

  Jeremy Grantham and Dick Mayo founded Batterymarch Financial Management before later establishing GMO.

A research-driven, contrarian asset manager emphasizing valuation discipline, mean reversion, long-term expected returns, and defensive positioning when market prices appear detached from fundamentals.

• Emerging-market debt · 1994

  GMO Emerging Country Debt Fund

  An emerging-country debt strategy that grew from a fund acquired by GMO in 1994. The predecessor fund focused on defaulted bank loans and Brady Bonds, giving the strategy a mandate distinct from conventional investment-grade fixed income. It represents GMO's participation in distressed and emerging-market credit alongside its broader value and asset-allocation activities.

• Equity strategy · 2020

  Equity Dislocation strategy

  A strategy launched in October 2020 to seek opportunities created by substantial dislocations in equity markets. Its reported 13.7% return during the 2022 stock-market decline made it a notable example of GMO's preference for valuation-driven and contrarian approaches during periods of market stress.

• Asset allocation

  Long-term asset-allocation research

  GMO's asset-allocation work uses long-term estimates of expected returns, valuation measures, and historical market relationships to compare asset classes. The research is closely connected to the firm's mean-reversion philosophy and is intended for investors willing to tolerate periods of divergence from prevailing market consensus.

• Equities

  Global and domestic equity strategies

  GMO manages equity strategies informed by valuation analysis and long-term expected-return assumptions. The firm's equity platform has included conservative, value-oriented, and emerging-market approaches, although individual mandates may differ in benchmark, geography, and risk exposure.

• 2023

  Emphasize deep-value stocksStrategy

  Background

  Following the 2022 market decline, GMO assessed that the cheapest stocks on valuation measures could lead a future market recovery.

  Action taken

  The firm issued a statement favoring deep-value stocks as a potential source of the next market resurgence.

  Aftermath

  The statement reinforced GMO's long-standing focus on valuation and mean reversion.

  Source

• 2020

  Acquire Usonian InvestmentsM&A

  Background

  GMO pursued additional equity-management capability in Japan.

  Action taken

  The firm acquired Usonian Investments, a Japan-based equity manager, in July 2020.

  Aftermath

  The transaction strengthened GMO's presence in Japanese equity management, although the supplied material gives no further transaction details.

  Source

• 2020

  Launch Equity Dislocation strategyProduct launch

  Background

  GMO identified market dislocations as a potential source of valuation-driven investment opportunities.

  Action taken

  The firm launched the Equity Dislocation strategy in October 2020.

  Aftermath

  The strategy reportedly returned 13.7% during the 2022 stock-market decline.

  Strategy return. 13.7% (2022)

  Source

• 2016

  Reduce workforceStrategy

  Background

  The firm faced changing assets under management and pressure associated with periods of underperformance during bullish markets.

  Action taken

  GMO reduced approximately 10% of a workforce of about 650 employees.

  Aftermath

  The reduction reportedly included the chief executive, but the supplied reference does not identify the person or provide a fuller management chronology.

  Source

• 1994

  Acquire an emerging-country debt fundM&A

  Background

  GMO sought to broaden its investment platform beyond its core conservative equity and asset-allocation activities.

  Action taken

  The firm acquired a fund established by Bill Nemerever and Thomas Cooper that invested in defaulted bank loans and Brady Bonds.

  Aftermath

  The acquired capability became associated with the GMO Emerging Country Debt Fund and added emerging-market and distressed-debt exposure.

  Source

1. 1GMO LLCen.wikipedia.org
2. 2GMO official websitegmo.com